Phreesia, Inc. (NYSE:PHR) Given Average Recommendation of "Moderate Buy" by Brokerages

Phreesia, Inc. (NYSE:PHR - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $29.42.

A number of equities research analysts have commented on the company. JMP Securities restated a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. JPMorgan Chase & Co. boosted their price objective on shares of Phreesia from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Monday, September 9th. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Canaccord Genuity Group reissued a "buy" rating and set a $34.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Finally, Truist Financial upped their price target on shares of Phreesia from $29.00 to $31.00 and gave the stock a "buy" rating in a research note on Friday, September 6th.

Phreesia Trading Down 0.1 %

Shares of Phreesia stock traded down $0.03 during trading on Wednesday, hitting $20.30. The stock had a trading volume of 207,085 shares, compared to its average volume of 447,396. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.17 billion, a PE ratio of -11.29 and a beta of 0.94. Phreesia has a 1 year low of $14.55 and a 1 year high of $29.16. The stock has a 50 day simple moving average of $20.63 and a 200 day simple moving average of $21.89.

Phreesia (NYSE:PHR - Get Free Report) last announced its earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.37) by $0.06. The company had revenue of $102.12 million for the quarter, compared to the consensus estimate of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. On average, research analysts expect that Phreesia will post -1.23 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other news, CEO Chaim Indig sold 5,295 shares of Phreesia stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total value of $123,108.75. Following the transaction, the chief executive officer now owns 1,223,736 shares of the company's stock, valued at $28,451,862. This trade represents a 0.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Balaji Gandhi sold 3,502 shares of the business's stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total transaction of $81,421.50. Following the completion of the sale, the chief financial officer now owns 98,578 shares of the company's stock, valued at $2,291,938.50. The trade was a 3.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 29,997 shares of company stock worth $667,943 over the last three months. Corporate insiders own 5.80% of the company's stock.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in the business. International Assets Investment Management LLC lifted its position in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after purchasing an additional 1,395 shares during the last quarter. nVerses Capital LLC increased its position in Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company's stock worth $64,000 after buying an additional 1,300 shares during the period. Lombard Odier Asset Management USA Corp acquired a new position in shares of Phreesia during the second quarter worth approximately $202,000. Quadrature Capital Ltd bought a new stake in shares of Phreesia in the first quarter valued at approximately $202,000. Finally, Point72 DIFC Ltd acquired a new stake in shares of Phreesia in the second quarter worth $209,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.